Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
19 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Bio-Incubator Leuven from Leuven, company number BE0876605232, closed financial year 2025 with a result of € -490,943 after tax. For that financial year Bio-Incubator Leuven recorded a gross margin of € 4.2 million and equity of € 9.2 million. Compared with financial year 2024, the result moved from € -1.1 million to € -490,943. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 9.2 million
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -490,943
▲ 54 % less loss than in 2024
Profit after tax over the fiscal year.
€ 3.9 million
▲ 111% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -5.5 million.
People and assets in 2025
7
▲ 1.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 637,232
▲ 14% vs 2024
€ 91,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 74,858
▼ 3% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 29.8 million
▼ 2% vs 2024
€ 3.1 million is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 834,643
▲ 62% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 162,754
▼ 17% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,484,533 | € 2,797,564 | € 3,525,552 | € 4,213,701 | ▲ 20% |
| Profit after taxes | € -506,799 | € -1,024,858 | € -1,077,642 | € -490,943 | ▲ € 586,699 |
| Equity | € 12,037,757 | € 10,873,321 | € 9,656,102 | € 9,180,699 | ▼ 5% |
| Total debts | € 23,381,117 | € 36,038,355 | € 34,410,630 | € 34,306,161 | |
| Cash | € 1,384,172 | € 4,104,753 | € 1,850,540 | € 3,910,827 | ▲ 111% |
| Land & buildings | € 25,820,274 | € 26,886,271 | € 38,432,163 | € 36,194,807 | ▼ 6% |
| Retained profit | € -2,904,309 | € -3,929,167 | € -5,006,809 | € -5,497,752 | ▼ € 490,943 |
| Bank debt | € 20,619,622 | € 31,851,180 | € 30,513,827 | € 29,834,792 | ▼ 2% |
| Balance sheet total | € 35,978,874 | € 47,471,676 | € 44,626,732 | € 44,046,860 | ▼ 1% |
| Employees (FTE) | 4.7 | 5.7 | 5.9 | 7 | ▲ 1.1 |
Key figures of Bio-Incubator Leuven, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Bio-Incubator Leuven?
What happened at Bio-Incubator Leuven in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 490,943. Source: NBB ↗
- Christelle Verrue stepped down as director. NBB
- Rik Audenaert stepped down as director. NBB
- Chris Buyse stepped down as director. NBB
- Jan Delcour stepped down as director. NBB
- MDBM BV stepped down as director. NBB
- Rik Audenaert became a director. NBB
- New establishment in Leuven. KBO
In short
From € 506,799 loss in 2022 to € 490,943 loss in 2025.
On average € 602,000 of value added per employee in 2025.
Management
The stake of VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY, Life Sciences Research Partners comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Bio-Incubator LeuvenThe shares are held by VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY (35.1%) and Life Sciences Research Partners (35.1%). It owns 23.7% of Parkeergebouw itself.
Directors
According to the 2025 annual accounts
since 2021 · until 2026
Rik Audenaert
Director
since 2024 · until 2026
since 2021 · until 2026
Jan Delcour
Managing director
since 2021 · until 2026
Managing director · represented by Michaël De Blauwe
Also active at: INNOVATIE- EN INCUBATIECENTRUM K.U. LEUVEN, nextAuth, INCUBATHOR WETENSCHAPSPARK WATERSCHEI, PARKEERGEBOUW, Open Thor Living Lab
since 2021 · until 2026
Shareholders
Participations
23.7%
Establishments
Establishment units
Physical locations of this company
Gaston Geenslaan 1
3001 Leuven
Gaston Geenslaan 2
3001 Leuven
Active since 16 October 2012
Gaston Geenslaan 3
3001 Leuven
Active since 1 October 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 19 companies are registered at this address.
All companies at this address →reMYND
€ -217,249 gross margin · 2025
DName-iT
€ -71,430 gross margin · 2025
miDiagnostics
€ 24,934 revenue · 2025
Pledge Therapeutics
€ -644,682 gross margin · 2025
PALEO
€ 1.5 million gross margin · 2025
+14 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0876.605.232
- VAT number
- BE 0876.605.232
- Registered office
- Gaston Geenslaan 1, 3001 Leuven
- Names & denominations
- Bio-Incubator Leuven
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 2005
- Peppol
- Active · Active since 17 Dec 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.